|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-5-9
|
|
pubmed:abstractText |
Minimally invasive coronary artery bypass grafting (CABG), carried out on the warm beating heart, does not allow conventional myocardial protection. The objective was to investigate the possibility of enhancing tolerance to ischemia during short episodes of coronary artery occlusion, based on a pharmacological approach using a selective Na(+)/H(+)-exchange inhibitor (cariporide) or a serine protease inhibitor (aprotinin).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1010-7940
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
633-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11343944-Animals,
pubmed-meshheading:11343944-Anti-Arrhythmia Agents,
pubmed-meshheading:11343944-Aprotinin,
pubmed-meshheading:11343944-Coronary Artery Bypass,
pubmed-meshheading:11343944-Guanidines,
pubmed-meshheading:11343944-Ischemic Preconditioning, Myocardial,
pubmed-meshheading:11343944-Myocardial Contraction,
pubmed-meshheading:11343944-Serine Proteinase Inhibitors,
pubmed-meshheading:11343944-Sheep,
pubmed-meshheading:11343944-Sodium-Hydrogen Antiporter,
pubmed-meshheading:11343944-Sulfones,
pubmed-meshheading:11343944-Surgical Procedures, Minimally Invasive
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Na(+)/H(+)-exchange inhibition and aprotinin administration: promising tools for myocardial protection during minimally invasive CABG.
|
|
pubmed:affiliation |
Limburgs Universitair Centrum, Universitaire Campus, 3590, Diepenbeek, Belgium. marc.hendrikx@virgajesse.be
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
